Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A
Charlotte K. Brierley, Bon Ham Yip, Giulia Orlando…·Adam J. Mead
The paper identifies chromothripsis-induced amplification of DYRK1A in blast phase MPN as a driver of aggressive disease and a potential therapeutic target.